BMS-986177

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

MelanomaStrokeLung Carcinoma

947 competitors in Melanoma

#DrugCompanyPhaseTrials

1

Lenvima

Eisai

Phase 3

92

Libtayo

Regeneron

Phase 3

63

Cyklokapron

AAmring

Phase 3

14

Spartalizumab

Novartis

Phase 3

25

ABP 234

Amgen

Phase 3

16

ABI-007

Bristol-Myers Squibb

Phase 3

17

Isolated Perfusion

NNational Cancer Institute (NCI)

Phase 3

18

Zelboraf

CConrado Roberto Hoffmann Filho

Preclinical

399

BMS-986177

Bristol-Myers Squibb

Phase 2

1410

Intron a

Merck & Co.

Preclinical

4Show 24 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tics4 trials

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT03224260·33 enrolled

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT03362437·12 enrolled

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects

Completed·Bristol-Myers Squibb·Phase 1·NCT02959060·16 enrolled

Show 1 more trial

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects

Completed·Bristol-Myers Squibb·Phase 1·NCT02807909·28 enrolled

Hepatic Impairment1 trial

Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT02982707·26 enrolled

End Stage Renal Disease (ESRD)1 trial

A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis

Completed·Bristol-Myers Squibb·Phase 1/2·NCT03000673·32 enrolled

Aspirin1 trial

An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT03341390·20 enrolled

ART1 trial

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT04965389·17 enrolled

6 more indications

Hemodialysis1 trial

A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Completed·Bristol-Myers Squibb·Phase 1·NCT02902679·6 enrolled

Metabolism1 trial

Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants

Completed·Bristol-Myers Squibb·Phase 1·NCT03939702·9 enrolled

Antiplatelet Therapy1 trial

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Completed·Bristol-Myers Squibb·Phase 1·NCT03698513·113 enrolled

Renal Impairment1 trial

Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

Completed·Bristol-Myers Squibb·Phase 1·NCT03196206·24 enrolled

Stroke1 trial

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Completed·Bristol-Myers Squibb·Phase 2·NCT03766581·2,366 enrolled

Unspecified1 trial

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

Completed·Bristol-Myers Squibb·Phase 1·NCT02608970·104 enrolled

Details

Drug Info

Related News